DYLAN PAYNE: Open Payments
NPI 1194985218 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 20 payments from 7 companies in 2025. Trend: 2023 $171 · 2024 $454 · 2025 $503
Food & beverage: $392Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $181 |
| Janssen Pharmaceuticals, Inc | 9 | $166 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Alkermes, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $14 |
Products named: INVEGA SUSTENNA, UZEDY, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA, ARISTADA, AUSTEDO XR, VRAYLAR.
Industry payments across PA — which companies pay providers there.
